1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 18
1.3 MARKET SCOPE 18
1.3.1 MARKETS COVERED 18
1.3.2 YEARS CONSIDERED FOR THE STUDY 20
1.4 CURRENCY AND PRICING 20
1.5 STAKEHOLDERS 20

2 RESEARCH METHODOLOGY 21
2.1 RESEARCH APPROACH 21
2.2 MARKET SIZE ESTIMATION 23
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 25
2.4 MARKET SHARE ESTIMATION 25
2.5 KEY DATA FROM SECONDARY SOURCES 26
2.6 KEY DATA FROM PRIMARY SOURCES 26
2.6.1 KEY INDUSTRY INSIGHTS 27
2.7 ASSUMPTIONS FOR THE STUDY 27

3 EXECUTIVE SUMMARY 28

4 PREMIUM INSIGHTS 32
4.1 GROWTH POTENTIAL OF THE NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET 32
4.2 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET: GEOGRAPHIC MIX 33
4.3 NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET IN ASIA-PACIFIC 34
4.1 NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 35
4.2 NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET, BY APPLICATION: GEOGRAPHIC MIX 36
4.3 NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET: DEVELOPING VS. DEVELOPED COUNTRIES 36

5 MARKET OVERVIEW 37
5.1 INTRODUCTION 38
5.2 MARKET SEGMENTATION 38
5.2.1 NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET, BY TYPE 38
5.2.2 NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET, BY APPLICATION 39
5.3 KEY MARKET DYNAMICS 39
5.3.1 MARKET DRIVERS 40
5.3.1.1 Increasing government support 40
5.3.1.2 Growing geriatric population 41
5.3.2 MARKET RESTRAINTS 42
5.3.2.1 Stringent and time-consuming product approval processes 42
5.3.2.2 High prices of nanotechnology-based medical devices 43
5.3.3 MARKET OPPORTUNITIES 43
5.3.3.1 Rich mid-to-late stage product pipeline 44
5.3.3.2 High growth opportunities in emerging markets 44
5.3.4 MARKET CHALLENGES 45
5.3.4.1 Commercialization of nanotechnology-based devices 45
5.3.4.2 Inadequate standards and lack of regulatory approval frameworks 46

6 INDUSTRY INSIGHTS 47
6.1 INTRODUCTION 47
6.2 VALUE CHAIN ANALYSIS 47
6.3 INDUSTRY TRENDS 49
6.3.1 INCREASING TREND TOWARDS INTERNATIONAL COLLABORATIONS 50
6.3.2 RISING NUMBER OF PUBLIC-PRIVATE PARTNERSHIPS 50
6.4 PORTER’S FIVE FORCES ANALYSIS 51
6.4.1 THREAT OF NEW ENTRANTS 51
6.4.2 THREAT OF SUBSTITUTES 52
6.4.3 BARGAINING POWER OF SUPPLIERS 52
6.4.4 BARGAINING POWER OF BUYERS 52
6.4.5 INTENSITY OF COMPETITIVE RIVALRY 52

7 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET,
BY PRODUCT 53
7.1 INTRODUCTION 54
7.2 ACTIVE IMPLANTABLE DEVICES 56
7.2.1 CARDIAC RHYTHM MANAGEMENT DEVICES 58
7.2.2 HEARING AID DEVICES 59
7.2.3 RETINAL IMPLANTS 60
7.3 BIOCHIPS 62
7.3.1 DNA MICROARRAYS 64
7.3.2 LAB-ON-A-CHIP 65
7.4 IMPLANTABLE MATERIALS 67
7.4.1 BONE SUBSTITUTE MATERIALS 69
7.4.2 DENTAL RESTORATIVE MATERIALS 70
7.5 MEDICAL TEXTILES AND WOUND DRESSINGS 72
7.6 OTHERS 74
?

8 NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET, BY APPLICATION 76
8.1 INTRODUCTION 77
8.2 THERAPEUTIC APPLICATIONS 78
8.3 RESEARCH APPLICATIONS 80
8.4 DIAGNOSTIC APPLICATIONS 82

9 GLOBAL NANOTECHNOLOGY-BASED MEDICAL DEVICES MARKET, BY REGION 84
9.1 INTRODUCTION 85
9.2 NORTH AMERICA 87
9.2.1 U.S. 91
9.2.2 CANADA 94
9.3 EUROPE 97
9.3.1 GERMANY 100
9.3.2 FRANCE 103
9.3.3 U.K. 106
9.3.4 ITALY 108
9.3.5 SPAIN 110
9.3.6 REST OF EUROPE 113
9.4 ASIA-PACIFIC 116
9.4.1 JAPAN 120
9.4.2 CHINA 123
9.4.3 INDIA 126
9.4.4 REST OF ASIA-PACIFIC 129
9.5 REST OF THE WORLD (ROW) 132
9.5.1 LATIN AMERICA 134
9.5.2 MIDDLE EAST AND AFRICA 137

10 COMPETITIVE LANDSCAPE 140
10.1 OVERVIEW 140
10.2 MARKET SHARE ANALYSIS 141
10.3 COMPETITIVE SITUATION AND TRENDS 143
10.4 NEW PRODUCT LAUNCHES 144
10.5 MERGERS AND ACQUISITIONS 145
10.6 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 146
10.7 OTHERS 146

11 COMPANY PROFILES 148
(Overview, Financials, Products & Services, Strategy, & Developments)*
11.1 INTRODUCTION 148
11.2 ST. JUDE MEDICAL, INC. 149
11.3 PERKINELMER, INC. 152
11.4 STARKEY HEARING TECHNOLOGIES 154
11.5 STRYKER CORPORATION 155
11.6 AFFYMETRIX, INC. 157
11.7 3M COMPANY 159
11.8 SMITH & NEPHEW PLC 162
11.9 MITSUI CHEMICALS, INC. 164
11.10 DENTSPLY INTERNATIONAL 167
11.11 AAP IMPLANTATE AG 169
*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

12 APPENDIX 171
12.1 INSIGHTS OF INDUSTRY EXPERTS 171
12.2 DISCUSSION GUIDE 172
12.3 AVAILABLE CUSTOMIZATIONS 174
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 175
12.5 RELATED REPORTS 177